![](/img/cover-not-exists.png)
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
Sherif Abdelaziz Ibrahim,Ramy Gadalla,Eslam A. El-Ghonaimy…Volume:
16
Language:
english
Journal:
Molecular Cancer
DOI:
10.1186/s12943-017-0621-z
Date:
December, 2017
File:
PDF, 6.26 MB
english, 2017